ArticleInternational journal of women's health2025
A Prognostic Nomogram Based on an Immunogenic Cell Death and Endoplasmic Reticulum Stress-Related Gene Signature for Ovarian Cancer.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating multiple omics and machine learning to reveal the prognostic value of endoplasmic reticulum stress geneTranslational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Gene signatures offer superior power on prognosis and survival of patients over traditional single-gene biomarker. This study aimed to develop a nomogram based on an immunogenic cell death (ICD) and endoplasmic reticulum (ER) stress-related gene signature to predict the overall survival (OS) of patients with ovarian cancer (OC). Materials and Methods: ICD- and ER stress-related genes were identified from public datasets and previous publications. Candidate genes were screened through differential expression and survival analyses. A prognostic risk score was established using Cox and LASSO regression. The model's predictive performance was evaluated by Kaplan-Meier and multivariate analyses, and a nomogram was constructed to estimate individual survival probabilities. Results: A seven-gene signature related to ICD and ER stress was developed to generate a prognostic risk score. Patients with low risk scores had significantly longer OS compared to high-risk patients. The signature correlated with immune features and remained an independent prognostic factor for OS in multivariate analysis. The prediction performance was good, with AUC values of 0.61, 0.64, and 0.67 for 1-, 2-, and 3-year OS in the training set, and 0.60, 0.61, and 0.60 in the validation set. The calibration curve showed good consistency between predicted and actual results. Conclusion: We established a clinically applicable nomogram integrating a seven-gene ICD/ER stress signature to provide individualized survival prediction for OC patients. This tool may assist clinicians in risk stratification and personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.